Victor Dzau

President, National Academy of Medicine

Victor Dzau is president of the National Academy of Medicine, where he has launched the Grand Challenge on Health Longevity. Prior to 2014, when he began his six-year term, Dzau served as chancellor for health affairs and president and CEO of Duke University Health System, and as chairman of medicine at both Stanford and Harvard. His research laid the foundation for angiotensin-converting-enzyme inhibitors, used to treat high blood pressure and congestive heart failure. He pioneered gene therapy for vascular disease and was the first to introduce DNA decoy molecules as gene therapy in humans. Dzau has chaired the National Institutes of Health Cardiovascular Disease Advisory Committee, among other service.

Videos/Audio of Victor Dzau

Individual genetic makeup and the genetic signature of diseases vary tremendously, but the goal of matching them with... See more
"Personalized medicine" holds great promise for optimizing the effectiveness of drug therapies based on our genetic... See more
The health industry's center of gravity is shifting. The inability of managed care and other current platforms to stem... See more